Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Organovo stock
Learn how to easily invest in Organovo stock.
Organovo is a biotechnology business based in the US. Organovo shares (ONVO) are listed on the NASDAQ and all prices are listed in US Dollars. Organovo employs 20 staff and has a trailing 12-month revenue of around $1.6 million.
How to buy Organovo stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ONVO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Organovo stock price (NASDAQ: ONVO)Use our graph to track the performance of ONVO stocks over time.
Organovo shares at a glance
|Latest market close||$1.65|
|52-week range||$1.37 - $4.67|
|50-day moving average||$1.58|
|200-day moving average||$2.19|
|Wall St. target price||$3.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.32|
Buy Organovo stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Organovo stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Organovo price performance over time
|1 week (2023-01-31)||1.23%|
|1 month (2023-01-04)||14.58%|
|3 months (2022-11-03)||5.77%|
|6 months (2022-08-03)||N/A|
|1 year (2022-02-07)||-48.92%|
|2 years (2021-02-05)||-88.95%|
|3 years (2020-02-07)||6.488|
|5 years (2018-02-07)||27.4|
|Revenue TTM||$1.6 million|
|Gross profit TTM||$-1,820,000|
|Return on assets TTM||-23.53%|
|Return on equity TTM||-40.35%|
|Market capitalisation||$14.7 million|
TTM: trailing 12 months
Organovo share dividends
We're not expecting Organovo to pay a dividend over the next 12 months.
Have Organovo's shares ever split?
Organovo's shares were split on a 1:20 basis on 18 August 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Organovo shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Organovo shares which in turn could have impacted Organovo's share price.
Organovo share price volatility
Over the last 12 months, Organovo's shares have ranged in value from as little as $1.37 up to $4.67. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Organovo's is 1.0024. This would suggest that Organovo's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Organovo Holdings, Inc. , a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California. .
Frequently asked questionsWhat percentage of Organovo is owned by insiders or institutions?
Currently 0.985% of Organovo shares are held by insiders and 17.15% by institutions. How many people work for Organovo?
Latest data suggests 20 work at Organovo. When does the fiscal year end for Organovo?
Organovo's fiscal year ends in March. Where is Organovo based?
Organovo's address is: 11555 Sorrento Valley Road, Solana Beach, CA, United States, 92121 What is Organovo's ISIN number?
Organovo's international securities identification number is: US68620A2033 What is Organovo's CUSIP number?
Organovo's Committee on Uniform Securities Identification Procedures number is: 68620A104
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert